May 21, 2018 / 11:08 AM / 3 months ago

BRIEF-Uniqure Presents New Data In Hemophilia B Patients

May 21 (Reuters) - Uniqure NV:

* UNIQURE PRESENTS NEW DATA DEMONSTRATING CLINICAL BENEFIT IN HEMOPHILIA B PATIENTS WITH PRE-EXISTING ANTI-AAV5 NEUTRALIZING ANTIBODIES

* UNIQURE NV - NEW DATA FURTHER DEMONSTRATING FAVORABLE IMMUNOGENICITY PROFILE OF AAV5

* UNIQURE NV - DATA SUGGEST AAV5 GENE THERAPIES MAY BE VIABLE TREATMENTS FOR AT LEAST 97% OF PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below